Eye cancer is most often detected during a routine dilated eye exam, sometimes before any symptoms appear. Many cases are caught when an eye doctor spots an abnormal growth or pigmented lesion while examining the back of the eye. When eye cancer is found while still localized, the five-year survival rate is 88%, making early detection genuinely life-changing.
Symptoms That Can Signal Eye Cancer
Eye cancer frequently causes no symptoms in its early stages, which is one reason routine exams matter so much. When symptoms do develop, they tend to affect only one eye and can include flashes of light, floaters (tiny specks drifting across your vision), blurry or worsening vision in one eye, a growing dark spot on the colored part of the eye, a change in pupil shape, or loss of side vision. None of these symptoms is unique to cancer. Floaters, for instance, are extremely common and usually harmless. But a new cluster of floaters paired with flashing lights, or a dark spot on the iris that wasn’t there before, warrants a prompt eye exam.
One symptom worth knowing about is a visible change in how light reflects from the pupil. In children especially, a white, silvery, or yellowish glow in the pupil, called leukocoria, can be a sign of retinoblastoma, the most common eye cancer in kids. Parents sometimes notice it first in flash photographs: instead of the normal red-eye effect, one pupil appears white. A small surface reflection in a single photo can be a normal glare artifact. But if the white reflection fills most of the pupil and shows up across multiple photos taken from different angles, that’s a reason to schedule a pediatric eye appointment quickly. About one in five cases of leukocoria in children turns out to be cancer-related.
What Happens During a Dilated Eye Exam
A comprehensive dilated eye exam is the single most important tool for catching eye cancer early. Your eye doctor places drops in your eyes to widen the pupils, then uses a magnifying instrument to examine the retina, the blood vessels, and the surrounding tissue at the back of the eye. This is how choroidal melanoma, the most common primary eye cancer in adults, is typically discovered. Many tumors sit behind the iris where they’re invisible from the outside, so dilation is essential.
The American Academy of Ophthalmology recommends that adults with no symptoms or risk factors get a baseline comprehensive eye exam at age 40. From there, the schedule depends on age: every two to four years between ages 40 and 54, every one to three years from 55 to 64, and every one to two years after 65. People at higher risk for eye disease, including Black adults who face elevated glaucoma risk, should start screening earlier and go more frequently.
Distinguishing Cancer From Harmless Growths
Not every dark spot inside the eye is cancer. Choroidal nevi, essentially freckles on the tissue lining the back of the eye, are common and almost always benign. The challenge is that small melanomas and benign nevi can look remarkably similar. Both can be pigmented or unpigmented, and both can appear in the same locations. Features that raise suspicion include fluid accumulating beneath the retina near the spot, the presence of orange pigment on the surface, and growth over time. When a doctor finds a suspicious lesion, they’ll often photograph it and schedule follow-up visits to monitor for changes before jumping to more invasive testing.
Imaging Tests Used to Confirm a Diagnosis
When a suspicious lesion is found, your doctor will typically order an ultrasound of the eye. This painless test uses high-frequency sound waves to create images of structures inside the eye. A small wand-like device is placed either on your closed eyelid or on the front surface of the eye. The ultrasound reveals the size, shape, and internal characteristics of a tumor, and experienced specialists can diagnose melanoma with about 95% accuracy using this test combined with a clinical exam.
Another common test is eye angiography. A colored dye is injected into a vein in your arm, and as it travels to the blood vessels in your eye, a special camera takes rapid photographs over several minutes. The resulting images map the blood vessel patterns around and within a tumor, helping doctors distinguish between different types of growths and plan treatment.
When a Biopsy Is Needed
Most eye cancers in adults are diagnosed without a biopsy, based on imaging and clinical appearance alone. A biopsy becomes necessary when the tumor doesn’t look like a textbook melanoma and the diagnosis is uncertain. In these cases, a fine-needle aspiration biopsy is performed: a thin needle is inserted into the tumor to withdraw a small sample of cells for analysis. This is a delicate procedure done under direct visualization, and it’s generally avoided for very small tumors (under about 2.5 millimeters in height) because the cellular yield is too low to be reliable.
In children, biopsy is typically not performed on suspected retinoblastoma. Piercing the tumor carries a risk of seeding cancer cells outside the eye, so diagnosis relies on imaging instead.
Beyond confirming the diagnosis, biopsy serves an increasingly important second purpose: predicting how aggressive a tumor will be. Genetic analysis of the biopsy sample can reveal whether the tumor has specific chromosome abnormalities, particularly the loss of one copy of chromosome 3. Tumors with this abnormality carry a significantly higher risk of eventually spreading to other parts of the body, especially the liver. A gene expression test that measures 15 genes simultaneously can classify a tumor’s risk profile from a tiny tissue sample, helping doctors determine how closely you’ll need to be monitored after treatment.
Who Should Evaluate a Suspicious Finding
A general ophthalmologist can detect a suspicious lesion and perform initial imaging. But if cancer is suspected, you’ll likely be referred to an ocular oncologist, a subspecialist who focuses specifically on eye tumors. These specialists work within multidisciplinary teams that can include retina specialists, radiation oncologists, medical oncologists, pathologists, and ophthalmic geneticists. This team approach matters because treatment decisions for eye cancer involve balancing tumor control against preserving as much vision as possible.
Ocular oncologists also monitor benign eye tumors over time, watching for the earliest signs of malignant transformation. If you’ve been told you have a choroidal nevus that needs watching, an ocular oncology center can offer the most precise surveillance with specialized imaging and measurement tools.
Why Early Detection Changes Outcomes
The survival gap between early and late-stage eye cancer is dramatic. When melanoma of the eye is still localized, the five-year relative survival rate is 88%. Once it has spread to nearby structures, that drops to 65%. If it has reached distant organs, survival falls to 19%. These numbers, based on patients diagnosed between 2015 and 2021, underscore why catching eye cancer before symptoms appear gives you the best possible outcome. For most people, the simplest step is keeping up with recommended eye exams, particularly after age 40 when the risk of many eye conditions begins to climb.